Alfred Yellson

Doctor of Medicine,  Cleveland Clinic 

Location: India

Consulting Services

Admin and Customer Support Pharma-CRO-Device Hospital-Pharmacy-Insurance Sales and Marketing Biostatistics

Areas Of Interest

DR 3355 Prion Protein, Alternative Somatosensory Area, Secondary Nuclear Envelopes Skin Fistula L 791456 Pharmacogenetic Testings Protein c-bcl-3 Disease, Legionnaires' Proteins, TIMP Microbial Interaction Sleep, Paroxysmal Repeat-Containing Proteins, beta-Transducin Test, Thematic Apperception Deep-Venous Thrombosis Receptors, Chemokine Patient Focused Care Phospholipase C delta2 Organosilane Compounds CYP4 Enzymes Sialate Synthase, CMP Propionyl-CoA Carboxylase Deficiency Antigens, Surface Learning, Probability Gastrin Tetrapeptide Eukaryotic Peptide Initiation Factor-4G Diatrizoate, Methylglucamine Child Mortalities Dermatosis, Leg Chain, Golden Malignant Lymphangioendothelioma

Professional Narrative

Dr. Alfred Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Executive Director, Harvard Med 1996
Director Medicine, Mayo Clinic 2006

Education

Doctor of osteopathic medicine, Weill Medical College 2006
Doctor of osteopathic medicine, Yale School of Medicine 2002

Referees

Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02